1.55
price down icon1.90%   -0.03
after-market 시간 외 거래: 1.61 0.06 +3.87%
loading

Tiziana Life Sciences Ltd 주식(TLSA)의 최신 뉴스

pulisher
Jun 16, 2025

Tiziana Life Sciences Ltd (TLSA) Stock: A Year of Stock Market Ups and Downs - investchronicle.com

Jun 16, 2025
pulisher
Jun 16, 2025

Promising Penny Stocks To Consider In June 2025 - simplywall.st

Jun 16, 2025
pulisher
Jun 13, 2025

Tiziana: Scope Of Foralumab Goes Beyond That Of Multiple Sclerosis Targeting (NASDAQ:TLSA) - Seeking Alpha

Jun 13, 2025
pulisher
Jun 13, 2025

Tiziana Life Sciences Adds Fifth Site for Phase 2 Foralumab Trial in Multiple Sclerosis - MarketScreener

Jun 13, 2025
pulisher
Jun 13, 2025

Small cap wrap: Tiziana Life Sciences, Challenger Energy, Arrow Exploration... - Proactive financial news

Jun 13, 2025
pulisher
Jun 13, 2025

Tiziana expands Phase 2 MS trial to fifth site, commences patient dosing - Proactive financial news

Jun 13, 2025
pulisher
Jun 13, 2025

Tiziana Life Sciences Expands Phase 2 Clinical Trial of Intranasal Foralumab with Commencement of First Patient Dosing at Weill Cornell Multiple Sclerosis Center - The Manila Times

Jun 13, 2025
pulisher
Jun 13, 2025

Breakthrough Multiple Sclerosis Treatment Enters Next Phase as Weill Cornell Joins Major Clinical Trial - Stock Titan

Jun 13, 2025
pulisher
Jun 13, 2025

Market movers: RH, Tiziana, Archer Aviation... - Proactive Investors

Jun 13, 2025
pulisher
Jun 13, 2025

Shares of Tiziana Life Sciences (TLSA) Climb on CEO's Upcoming P - GuruFocus

Jun 13, 2025
pulisher
Jun 13, 2025

Tiziana shares rise on presentation date for foralumab data - Seeking Alpha

Jun 13, 2025
pulisher
Jun 13, 2025

Tiziana CEO to present clinical advances of intranasal foralumab at BIO 2025 - Proactive financial news

Jun 13, 2025
pulisher
Jun 13, 2025

Tiziana Life Sciences to Present at the Bio International Convention - The Manila Times

Jun 13, 2025
pulisher
Jun 13, 2025

Revolutionary Intranasal Treatment for MS and Alzheimer's: Tiziana CEO Reveals Latest Clinical Findings at BIO 2025 - Stock Titan

Jun 13, 2025
pulisher
May 27, 2025

Tiziana Life Sciences Ltd (TLSA) Stock: A Comprehensive 52-Week Review - investchronicle.com

May 27, 2025
pulisher
May 27, 2025

Tiziana Life Sciences (NASDAQ:TLSA) Stock Price Up 15.3% – Still a Buy? - Defense World

May 27, 2025
pulisher
May 23, 2025

TLSA Advances Alzheimer's Treatment with Innovative Nasal Spray - GuruFocus

May 23, 2025
pulisher
May 23, 2025

Tiziana Life Sciences Announces Interview Highlighting Intranasal Foralumab for the Treatment of Moderate Alzheimer's Disease - marketscreener.com

May 23, 2025
pulisher
May 23, 2025

Tiziana Life Sciences Announces Interview Highlighting Intranasa - GuruFocus

May 23, 2025
pulisher
May 23, 2025

Tiziana Life Sciences Announces Interview Highlighting Intranasal Foralumab for the Treatment of Moderate Alzheimer's Disease | TLSA Stock News - GuruFocus

May 23, 2025
pulisher
May 23, 2025

Tiziana Life Sciences Announces Breakthrough Advancement in Moderate Alzheimer’s Treatment with Intranasal Foralumab - Nasdaq

May 23, 2025
pulisher
May 23, 2025

Breakthrough: First Alzheimer's Patient Shows Improvement with Revolutionary Nasal Antibody Treatment - Stock Titan

May 23, 2025
pulisher
May 16, 2025

Journal of Clinical Nuclear Medicine Publishes Results of Tiziana’s Nasal Foralumab in Study Treating Moderate Alzheimer's Disease - BioSpace

May 16, 2025
pulisher
May 16, 2025

Small cap wrap: Lancaster Resources, Cerro de Pasco, Tiziana Life Sciences, Nano One Materials... - Proactive financial news

May 16, 2025
pulisher
May 15, 2025

Tiziana reports reduction in microglial activation in Alzheimer’s case treated with nasal foralumab - Proactive financial news

May 15, 2025
pulisher
May 15, 2025

TLSA: Tiziana Life Sciences Study Shows Promise for Alzheimer's Treatment | TLSA Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Journal of Clinical Nuclear Medicine Publishes Results of Tiziana's Nasal Foralumab in Study Treating Moderate Alzheimer's Disease - The Manila Times

May 15, 2025
pulisher
May 15, 2025

Journal Of Clinical Nuclear Medicine Publishes Results Of Tiziana’S Nasal Foralumab In Study Treating Moderate Alzheimer's Disease - MENAFN.com

May 15, 2025
pulisher
May 15, 2025

Journal of Clinical Nuclear Medicine Publishes Results of - GlobeNewswire

May 15, 2025
pulisher
May 15, 2025

Revolutionary Nasal Treatment Reduces Brain Inflammation in Moderate Alzheimer's Patient, Harvard Study Shows - Stock Titan

May 15, 2025
pulisher
May 12, 2025

Tiziana Life Sciences chairman increases stake to over 37% - Proactive financial news

May 12, 2025
pulisher
May 12, 2025

Executive Chairman Increases Stake in Tiziana Life Sciences (TLS - GuruFocus

May 12, 2025
pulisher
May 12, 2025

Tiziana Life Sciences Announces Purchase of Shares by Chairman - The Manila Times

May 12, 2025
pulisher
May 10, 2025

Tiziana reports promising Alzheimer’s treatment results By Investing.com - Investing.com Nigeria

May 10, 2025
pulisher
May 10, 2025

Tiziana reports promising Alzheimer’s treatment results - Investing.com

May 10, 2025
pulisher
May 09, 2025

Tiziana Life Sciences Announces Significant Reduction in Microglia Activation in PET Scan of Moderate Alzheimer's Patient Treated with Intranasal Foralumab - BioSpace

May 09, 2025
pulisher
May 09, 2025

Tiziana Reports PET data sees reduced neuroinflammation in patient treated with Intranasal Therapy - Proactive Investors

May 09, 2025
pulisher
May 09, 2025

Market movers: Lyft, US Gold, Tiziana Life Sciences... - Proactive Investors

May 09, 2025
pulisher
May 09, 2025

Tiziana Life Sciences reports reduced brain inflammation in Alzheimer’s patient treated with nasal foralumab - Proactive Investors

May 09, 2025
pulisher
May 09, 2025

TLSA: Tiziana Life Sciences Reports Positive PET Scan Results in Alzheimer's Treatment | TLSA Stock News - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Tiziana stock gains on data for Alzheimer's drug (TLSA:NASDAQ) - Seeking Alpha

May 09, 2025
pulisher
May 09, 2025

Tiziana Life Sciences Announces Significant Reduction In Microglia Activation In PET Scan Of Moderate Alzheimer's Patient Treated With Intranasal Foralumab - MENAFN.com

May 09, 2025
pulisher
May 09, 2025

Tiziana Life Sciences Announces Significant Reduction in - GlobeNewswire

May 09, 2025
pulisher
May 08, 2025

Tiziana Life Sciences’ intranasal MS candidate shows promise in open-label study - PMLiVE

May 08, 2025
pulisher
May 06, 2025

Small cap wrap: Tiziana Life Sciences, Millennial Potash, Century LIthium... - Proactive financial news

May 06, 2025
pulisher
May 06, 2025

Tiziana shares surge 21% on promising multiple sclerosis data - Proactive financial news

May 06, 2025
pulisher
May 06, 2025

Tiziana rises on positive results in multiple sclerosis treatment study - Seeking Alpha

May 06, 2025
pulisher
May 06, 2025

Tiziana reports encouraging results for nasal MS drug in early study - Proactive Investors

May 06, 2025
pulisher
May 06, 2025

TLSA's Nasal Foralumab Shows Promise in MS Treatment Study | TLS - GuruFocus

May 06, 2025
pulisher
May 06, 2025

TLSA's Nasal Foralumab Shows Promise in MS Treatment Study | TLSA Stock News - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Clinical Trial Success: Revolutionary Nasal Spray Halts Multiple Sclerosis Progression in Landmark Study - Stock Titan

May 06, 2025
pulisher
May 06, 2025

Tiziana shares surge 21% on promising multiple sclerosis data | NASDAQ:TLSA - Proactive Investors

May 06, 2025
pulisher
May 06, 2025

Tiziana shares surge on encouraging results for nasal MS drug in early study - Proactive financial news

May 06, 2025
pulisher
May 04, 2025

Geode Capital Management LLC Raises Stock Holdings in Tiziana Life Sciences Ltd (NASDAQ:TLSA) - Defense World

May 04, 2025
pulisher
Apr 30, 2025

Tiziana Life Sciences Delays Annual Report Filing - TipRanks

Apr 30, 2025
$20.74
price up icon 0.39%
$35.88
price down icon 0.42%
$21.20
price down icon 0.38%
$97.62
price down icon 3.00%
$107.51
price up icon 0.98%
biotechnology ONC
$245.16
price up icon 1.28%
자본화:     |  볼륨(24시간):